Showing 66,581 - 66,600 results of 70,031 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.53s Refine Results
  1. 66581

    Increased apoptosis, gliosis, mitochondria dysfunction and gliocentric cell fate shift in DS HNPs. by Jie Lu (139953)

    Published 2011
    “…(B) The increase in programmed progenitor cell death seen <i>in vivo</i> is also appreciated <i>in vitro</i> in human DS neurospheres after one week of culture. …”
  2. 66582
  3. 66583
  4. 66584
  5. 66585
  6. 66586
  7. 66587

    Video_3_Mapping of the supplementary motor area using repetitive navigated transcranial magnetic stimulation.MP4 by Giulia Kern (16009760)

    Published 2023
    “…Further, the lower extremity was mapped at 20 Hz (140%RMT) using a toe tapping task.</p>Results<p>Mean finger tapping scores decreased significantly during stimulation (25.70taps) compared to baseline (30.48; p < 0.01). …”
  8. 66588

    Video_2_Mapping of the supplementary motor area using repetitive navigated transcranial magnetic stimulation.MP4 by Giulia Kern (16009760)

    Published 2023
    “…Further, the lower extremity was mapped at 20 Hz (140%RMT) using a toe tapping task.</p>Results<p>Mean finger tapping scores decreased significantly during stimulation (25.70taps) compared to baseline (30.48; p < 0.01). …”
  9. 66589
  10. 66590
  11. 66591
  12. 66592
  13. 66593
  14. 66594
  15. 66595
  16. 66596
  17. 66597

    Image_2_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Both topical (RR 0.19, 95% CI 0.08–0.45, P < 0.001) and subconjunctival anti-VEGF agents (RR 0.64, 95% CI 0.45–0.91, P = 0.01) had a positive influence on recurrence. There was no statistically significant difference in complications between the groups (RR 0.80, 95% CI 0.52–1.22, P = 0.29).…”
  18. 66598

    Image_3_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Both topical (RR 0.19, 95% CI 0.08–0.45, P < 0.001) and subconjunctival anti-VEGF agents (RR 0.64, 95% CI 0.45–0.91, P = 0.01) had a positive influence on recurrence. There was no statistically significant difference in complications between the groups (RR 0.80, 95% CI 0.52–1.22, P = 0.29).…”
  19. 66599

    Image_4_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

    Published 2023
    “…Both topical (RR 0.19, 95% CI 0.08–0.45, P < 0.001) and subconjunctival anti-VEGF agents (RR 0.64, 95% CI 0.45–0.91, P = 0.01) had a positive influence on recurrence. There was no statistically significant difference in complications between the groups (RR 0.80, 95% CI 0.52–1.22, P = 0.29).…”
  20. 66600